QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a ...
The case for replacing age-based breast cancer screening with personalized risk-based screening is gaining strength — with recent studies showing the approach is feasible and has the potential to save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results